Literature DB >> 19145203

Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung.

Wilko Weichert1, Christiane Schewe, Carsten Denkert, Lars Morawietz, Manfred Dietel, Iver Petersen.   

Abstract

In this study, typing of human papilloma virus (HPV) was performed in squamous cell carcinomas of the lung (n=26) as well as putative primaries of head and neck (n=21) and female genital tract (n=5) of the same patients, to test whether additional information to discriminate lung primaries from metastases can be gained by a direct comparison of the HPV status in both tumors. In 3 (14.2%) patients with head and neck as well as lung squamous cell carcinoma, an identical HPV subtype could be detected in both tumors suggesting metastatic disease. In 9 (42.9%) cases, discordant HPV status strongly suggested secondary primaries of the lung. In the remaining 9 (42.9%) patients, no HPV was evident in either tumor. In all patients with carcinomas of the cervix uteri an identical HPV subtype was detected in the cervical and in the lung tumor. In conclusion, the results suggest HPV typing, a method routinely used in cervical biopsies for years, as a very useful diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung, which in our cohort in 57.1% of cases allowed for almost definite classification.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19145203     DOI: 10.1097/PAS.0b013e3181938319

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

Review 1.  The morphological and molecular diagnosis of lung cancer.

Authors:  Iver Petersen
Journal:  Dtsch Arztebl Int       Date:  2011-08-08       Impact factor: 5.594

2.  Human papilloma virus: differentiating new primary lung cancer versus metastatic disease from previous head and neck squamous cell carcinoma.

Authors:  Meredith E Giuliani; Ilan Weinreb; Andrew J Hope
Journal:  BMJ Case Rep       Date:  2011-02-24

Review 3.  [Morphological and molecular pathology of lung cancer].

Authors:  I Petersen
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 4.  The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management.

Authors:  William H Westra
Journal:  Head Neck Pathol       Date:  2012-07-03

5.  HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.

Authors:  Justin A Bishop; Takenori Ogawa; Xiaofei Chang; Peter B Illei; Edward Gabrielson; Sara I Pai; William H Westra
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

6.  The Fidelity of p16 Staining as a Surrogate Marker of Human Papillomavirus Status in Fine-Needle Aspirates and Core Biopsies of Neck Node Metastases: Implications for HPV Testing Protocols.

Authors:  Brittany J Holmes; Zahra Maleki; William H Westra
Journal:  Acta Cytol       Date:  2015-03-10       Impact factor: 2.319

7.  Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas.

Authors:  William H Westra
Journal:  Oral Oncol       Date:  2014-06-02       Impact factor: 5.337

Review 8.  [HPV in non-gynecological tumors].

Authors:  I Petersen; F Klein
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

9.  [Human papillomavirus in squamous cell cancer of the head and neck. A study at the Ulm Military Hospital, Germany].

Authors:  M Maier; K Kraft; K Steinestel; A Schramm; K J Lorenz; M Tisch; M Schwerer; H Maier
Journal:  HNO       Date:  2013-07       Impact factor: 1.284

10.  Transcriptionally-active human papillomavirus is consistently retained in the distant metastases of primary oropharyngeal carcinomas.

Authors:  Mitra Mehrad; Hongwei Zhao; Ge Gao; Xiaowei Wang; James S Lewis
Journal:  Head Neck Pathol       Date:  2013-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.